|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1997-8-14
|
|
pubmed:abstractText |
The process of ocular wound healing with respect to glaucomatous filtering procedures is of current interest. Delaying this response in patients could possibly lead to more favorable surgical results. So far, only highly toxic antimetabolites have come into frequent clinical use. The possible efficacy of other groups of substances such as growth factor inhibitors has not yet been examined in vitro.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0721-832X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
235
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
399-403
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:9202971-Antineoplastic Agents,
pubmed-meshheading:9202971-Cell Line,
pubmed-meshheading:9202971-Collagen,
pubmed-meshheading:9202971-Connective Tissue,
pubmed-meshheading:9202971-Connective Tissue Cells,
pubmed-meshheading:9202971-Decorin,
pubmed-meshheading:9202971-Dose-Response Relationship, Drug,
pubmed-meshheading:9202971-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:9202971-Extracellular Matrix Proteins,
pubmed-meshheading:9202971-Fibroblasts,
pubmed-meshheading:9202971-Humans,
pubmed-meshheading:9202971-Proteoglycans,
pubmed-meshheading:9202971-Suramin,
pubmed-meshheading:9202971-Wound Healing
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Decorin and suramin inhibit ocular fibroblast collagen production.
|
|
pubmed:affiliation |
Department of Pathology, Baylor College of Medicine, Houston, Texas, USA. h.mietz@uni-koeln.de
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
